immo!nvest – Die Plattform für Standorte und Immobilien

Tag: Life Science

  • Innovation City opens second life science campus in Reinach

    Innovation City opens second life science campus in Reinach

    The Basel-based association Innovation City(iCity) is opening its second campus in Reinach. According to its own information, life sciences start-ups will be able to push ahead with their scientific progress and the establishment of their company in the Kägen industrial and commercial area.

    The young companies will have access to a “state-of-the-art and optimally equipped life science location” on an area of around 7000 square metres, according to a quote from Melchior Buchs, president of the Reinach municipality.

    On two floors, 3,500 square metres are planned for laboratory facilities – both for flex labs and for shared labs in cooperation with the partners Vebego, Move Consultants AG and UBS Sima. The laboratories are standardised according to Biosafety Level 2. Two further floors offer 3400 square metres of coworking space with areas for meeting and networking as well as offices, seminar and strategy rooms.

    iCity is an initiative that brings together start-ups, investors and researchers from the life science sector. The expansion is iCity’s response to the growing need for “affordable laboratory facilities in the Basel region that can be used at short notice”, it says.

    The family-friendly concept includes daycare places directly on the premises and a dining offer from the Compass Group. The campus is scheduled to open in August 2023.

  • Another location for start-ups is being created in the greater Zurich area

    Another location for start-ups is being created in the greater Zurich area

    As a first step, Elektron AG is making around 1,100 square meters available to the Wädenswil start-up organization grow . Two fast-growing life science start-ups will move in there: Araris Biotech AG , a spin-off from the Swiss Federal Institute of Technology Zurich ( ETH ) and the Paul Scherrer Institute ( PSI ), and Nemis Technologies AG . This is already a fourth location for ambitious young companies in the local area of Wädenswil.

    The technology company Elektron will finance the conversion to laboratory and office space. “The cooperation with grow fits perfectly with our philosophy of combining modern technologies and sustainability,” Elektron CEO Enrico Baumann is quoted as saying in a statement from grow. “For us, the settlement of the two start-ups is an investment in the future and a commitment to the Wädenswil workplace.”

    Araris Biotech is researching novel anti-cancer antibody compounds. Nemis develops diagnostic solutions to detect pathogenic bacteria in food. Both have completed successful financing rounds. Araris was able to earn over 15 million francs in October 2020, Nemis only recently 7.75 million francs.

    “In the past five years, growth has accelerated significantly,” says Wädenswil Mayor Philipp Kutter. He is also a member of the board of trustees of grow. Despite the corona pandemic, there are signs of further growth, “which is extremely positive for research and business in and around Wädenswil”.